Biomarin Pharmaceutical shares owned by UBS Group
Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Biomarin Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Biomarin Pharmaceutical held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biomarin Pharmaceutical by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $141k | 147k | 0.96 |
| 2025-09-30 | $1.9k | 2.0k | 0.95 |
| 2025-06-30 | $941 | 1.0k | 0.94 |
| 2025-03-31 | $941 | 1.0k | 0.94 |
| 2024-12-31 | $3.2M | 3.5M | 0.93 |
| 2023-06-30 | $10k | 10k | 1.01 |
| 2023-03-31 | $7.3k | 7.0k | 1.04 |
| 2022-12-31 | $752k | 7.0k | 107.46 |
| 2022-09-30 | $6.0k | 6.0k | 1.00 |
| 2022-06-30 | $8.0k | 8.0k | 1.00 |
| 2022-03-31 | $10k | 10k | 1.00 |
| 2021-12-31 | $12k | 12k | 1.00 |
| 2021-09-30 | $16k | 16k | 1.00 |
| 2021-06-30 | $16k | 16k | 1.00 |